Last updated: February 16, 2026
What is the current market status and projected price for NDC 68180-0404?
The NDC 68180-0404 corresponds to a specific formulation of a pharmaceutical product. As of the latest available data, this drug is primarily used in specific therapeutic areas, though detailed market and price information is limited due to proprietary and competitive factors.
What is the current market landscape for this drug?
Market Segments
- Indications and Uses: The drug treats certain conditions, predominantly in the outpatient and specialized clinics.
- Regulatory Status: It has FDA approval, with patent protections or exclusivity periods possibly influencing market dynamics.
- Manufacturers: Several generic and branded manufacturers distribute the drug, influencing competitive pricing.
Market Size and Sales Trends
- Sales Figures: Estimated U.S. sales reach approximately $XX million annually, based on data from IQVIA or similar sources.
- Market Penetration: The product holds a XX% share in its therapeutic category.
- Growth Drivers: Rising prevalence of disease conditions, increasing healthcare access, and expanding indications aid sales growth.
- Constraints: Competition from generics, pricing pressures, and reimbursement policies limit revenue potential.
What are the current pricing levels?
Average Wholesale Price (AWP)
- The AWP for this product is approximately $XX per unit or dose.
- Typical pack prices range from $XX to $XX, depending on dosage and form.
Pharmacy Acquisition Cost
- The average acquisition cost to pharmacies is estimated at 25-30% below the AWP.
- Insurance reimbursements often set at similar levels, influencing net revenue.
Pricing Dynamics
| Factor |
Impact |
| Competition from generics |
Drives prices downward, often by 50% or more within 12-24 months post-patent expiry |
| Reimbursement policies |
Can restrict pricing, leading to managed care negotiations |
| Manufacturing costs |
Slight influence; costs are stable relative to price changes |
What projections are feasible for future pricing?
Short-term (next 1-2 years):
- Prices are expected to remain stable, assuming no patent challenges or market entry of alternative therapies.
- Price declines of 10-15% are typical following patent expiration, due to generic competition.
Mid to long-term (3-5 years):
- If patent exclusivity continues, prices could sustain or slightly increase due to inflation or value-based pricing models.
- Entry of biosimilars or generics could reduce prices by 40-70% within 2-3 years post-patent expiration.
Impact of Regulations
- Price caps, reimbursement reform, or new formulary restrictions could influence prices downward.
- Legislative pressure on drug pricing—such as proposals to cap Medicare and Medicaid drug costs—could constrain reimbursements.
What are the key factors influencing future price trends?
- Patent protection status: Exclusivity length determines timing of generic entry.
- Market competition: Number of competing products influences price erosion.
- Demand trends: Growth in target patient population sustains prices.
- Regulatory shifts: Price control measures could restrict price increases.
- Cost of manufacturing and distribution: Generally stable but could influence break-even points.
What are the most relevant comparables and benchmarks?
| Drug Name |
Market Share |
Current Price Range |
Patent Expiry |
Price Reduction Post-Patent |
| [Comparable drug 1] |
XX% |
$XX - $XX per dose |
202X |
50-70% within 2 years |
| [Comparable drug 2] |
YY% |
$XX per vial |
202Y |
40-60% within 1-2 years |
Since specific public pricing is limited by confidentiality, projecting precise prices relies on modeling based on comparable drugs' historic trends and patent status.
What are the key takeaways?
- The current market for NDC 68180-0404 is stable with moderate sales.
- Pricing closely follows patent status; generic entry is the primary pricing factor.
- Short-term prices are likely to stabilize; significant reductions expected after patent expiry.
- Regulatory and reimbursement dynamics could influence future pricing, with legislative proposals possibly constraining prices.
- Investment and R&D decisions should consider patent timelines and competition landscape.
FAQs
1. When is the patent for NDC 68180-0404 expiring?
Patent expiration estimates depend on the patent filing and approval date; confirm through FDA or patent databases for precise timing.
2. Are biosimilars or generics expected to enter the market soon?
If patents expire soon or have expired, generic manufacturers typically pursue approvals within 6-12 months.
3. How do reimbursement policies impact drug pricing?
Reimbursement limits set by payers influence pharmacy and provider prices, often favoring lower-cost alternatives.
4. What are the main risks to price stability?
Patent challenges, regulatory price caps, and aggressive generic competition pose significant risks.
5. How should investors evaluate future market potential?
Consider patent status, competition, that specific indications persist with growing patient populations, and evolving healthcare policies.
References
- IQVIA. Industry Sales Data. (2022-2023)
- FDA. NDC Directory. https://www.fda.gov/drugs/drug-approvals-and-databases
- SSR Health. 2022 U.S. Drug Pricing Reports.
- Deloitte. Pharmaceutical Market Trends. 2022.
- FDA. List of Approved Drugs and Patent Status.
